Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥2,207,000 | ¥2,727,000 | ¥3,607,000 | ¥4,381,000 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥20,254,000 | ¥15,441,000 | ¥17,654,000 | ¥16,146,000 |
| Inventory | ¥18,412,000 | ¥20,890,000 | ¥18,238,000 | ¥16,820,000 |
| Other Curr. Assets | ¥835,000 | ¥2,402,000 | ¥1,164,000 | ¥562,000 |
| Total Curr. Assets | ¥41,708,000 | ¥41,460,000 | ¥40,663,000 | ¥37,909,000 |
| Property Plant & Equip (Net) | ¥31,826,000 | ¥31,972,000 | ¥25,837,000 | ¥23,116,000 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥531,000 | ¥490,000 | ¥377,000 | ¥386,000 |
| Long-Term Investments | ¥2,091,000 | ¥3,188,000 | ¥3,169,000 | ¥2,958,000 |
| Tax Assets | ¥359,000 | ¥320,000 | ¥504,000 | ¥570,000 |
| Other NC Assets | ¥1,489,000 | ¥278,000 | ¥0 | -¥1,000 |
| Total NC Assets | ¥36,296,000 | ¥36,248,000 | ¥29,887,000 | ¥27,029,000 |
| Other Assets | ¥0 | ¥3,000 | ¥2,000 | ¥1,000 |
| Total Assets | ¥78,004,000 | ¥77,708,000 | ¥70,552,000 | ¥64,939,000 |
| Liabilities | – | – | – | – |
| Payables | ¥8,266,000 | ¥8,699,000 | ¥4,435,000 | ¥4,493,000 |
| Short-Term Debt | ¥3,457,000 | ¥2,099,000 | ¥1,498,000 | ¥1,200,000 |
| Tax Payable | ¥0 | ¥195,000 | ¥559,000 | ¥1,402,000 |
| Deferred Revenue | ¥0 | ¥0 | ¥5,379,000 | ¥4,489,000 |
| Other Curr. Liab. | ¥4,851,000 | ¥7,237,000 | -¥187,000 | ¥465,000 |
| Total Curr. Liab. | ¥17,049,000 | ¥18,505,000 | ¥15,428,000 | ¥14,069,000 |
| LT Debt | ¥6,569,000 | ¥4,669,000 | ¥3,368,000 | ¥2,247,000 |
| Deferred Rev, NC | ¥0 | ¥5,000 | ¥507,000 | ¥755,000 |
| Deferred Tax Liab, NC | ¥30,000 | ¥32,000 | ¥31,000 | ¥32,000 |
| Other NC Liab. | ¥426,000 | ¥557,000 | ¥170,000 | ¥165,000 |
| Total NC Liab. | ¥8,884,000 | ¥6,939,000 | ¥4,153,000 | ¥3,199,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥1,951,000 | ¥92,000 | ¥0 |
| Total Liabilities | ¥25,933,000 | ¥25,444,000 | ¥19,581,000 | ¥17,268,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥49,141,000 | ¥0 |
| Common Stock | ¥7,186,000 | ¥7,186,000 | ¥7,186,000 | ¥7,031,000 |
| Retained Earnings | ¥37,179,000 | ¥37,087,000 | ¥35,006,000 | ¥32,338,000 |
| AOCI | ¥1,314,000 | ¥1,712,000 | ¥1,531,000 | ¥1,031,000 |
| Other Equity | ¥1,000 | ¥2,000 | ¥0 | ¥0 |
| Total Equity | ¥52,003,000 | ¥52,069,000 | ¥50,672,000 | ¥47,304,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥64,000 | ¥196,000 | ¥299,000 | ¥367,000 |
| Total Liab. & Tot. Equity | ¥78,004,000 | ¥77,708,000 | ¥70,552,000 | ¥64,939,000 |
| Net Debt | ¥7,819,000 | ¥4,041,000 | ¥1,259,000 | -¥934,000 |